Immediate Impact
1 from Science/Nature 61 standout
Citing Papers
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Works of Jim Vaught being referenced
Biospecimen Reporting for Improved Study Quality (BRISQ)
2011
Biospecimen reporting for improved study quality (BRISQ)
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jim Vaught | 557 | 303 | 412 | 333 | 35 | 1.3k | |
| Karen Kwan | 361 | 189 | 593 | 233 | 19 | 1.6k | |
| Stella Somiari | 278 | 175 | 719 | 384 | 28 | 1.3k | |
| Yaffa Rubinstein | 264 | 105 | 630 | 291 | 29 | 1.4k | |
| Manuel M. Morente | 304 | 182 | 611 | 341 | 48 | 1.6k | |
| Sheri D. Schully | 282 | 74 | 289 | 217 | 55 | 1.4k | |
| W. David Dotson | 278 | 77 | 324 | 358 | 33 | 1.6k | |
| Julie Dang | 334 | 75 | 288 | 201 | 37 | 1.2k | |
| Helen M. Moore | 160 | 94 | 629 | 441 | 36 | 1.3k | |
| L. S. Freedman | 263 | 123 | 154 | 142 | 49 | 1.2k | |
| Jennifer Liu | 186 | 81 | 273 | 113 | 46 | 1.3k |
All Works
Loading papers...